Latest Financials News

Platina Resources reported steady progress across multiple Western Australian gold projects in the June 2025 quarter, balancing promising drill results with operational hurdles and a solid cash position.

Memphasys Limited has submitted its Felix™ sperm separation system for CE Mark approval, targeting Europe’s $5 billion IVF market, while expanding direct sales in Japan and validating its RoXsta™ oxidative stress diagnostic platform.

Jatcorp Limited reported a robust 76% revenue increase in Q4 FY25, driven by strong Moroka® sales and expanded manufacturing capabilities, setting ambitious growth targets for FY26.

Stelar Metals has been granted a new exploration licence in South Australia targeting titanium-rich heavy mineral sands, while also uncovering promising tin potential at its New South Wales Trident Project.

Octava Minerals has successfully completed the initial phase of its $1.5 million capital raise, positioning the company to advance exploration and due diligence at its promising Federation Copper-Zinc-Silver Project.

Diatreme Resources has achieved a significant milestone with its Northern Silica Project awarded Major Project Status and a 278% upgrade in its Si2 Deposit resource, positioning the company for long-term growth in the critical minerals sector.

Gladiator Resources reported promising uranium and rare metal findings at its Tanzanian projects while initiating legal action over alleged defamation, all against a backdrop of cautious cash management.

Uvre Limited has secured a transformative portfolio of New Zealand gold projects, including the high-grade Waitekauri asset, backed by a $4 million capital raise and new board appointments. The company is gearing up for its maiden drilling campaign this September.

Altech Batteries confirms the safety and durability of its CERENERGY® sodium-nickel-chloride battery technology through rigorous testing, while its Silumina Anodes™ pilot plant in Germany achieves a 50% capacity increase. An independent DNV study endorses the technology’s promising future.

Orion Minerals reported significant cash outflows in its June 2025 quarter, with liquidity stretched and financing facilities nearly maxed out. The company is pursuing a $5.8 million capital raising to support ongoing operations following recent feasibility study completions.

Orion Minerals is advancing its Prieska Copper Zinc Mine towards production, targeting first concentrate by Christmas 2026, supported by a recent $5.8 million capital raise and ongoing project optimisation.

Alterity Therapeutics has secured U.S. FDA Fast Track designation for its drug ATH434 targeting Multiple System Atrophy, supported by promising Phase 2 clinical trial data showing slowed disease progression and a solid safety profile.